BullFrog AI Holdings BFRG
NASDAQ BFRG
$0.50 +0.01 (+2.04%)
At close: Sep 4, 2026 · 4:00 PM EDT

BullFrog AI Holdings (BFRG) Cash from Financing Activities (2022 - 2025)

BullFrog AI Holdings' (BFRG) quarterly Cash from Financing Activities came in at $1.4 million in Q4 2025, down 44.19% on a YoY basis from $2.5 million in Q4 2024, and up 120.74% quarter-over-quarter from $624249.0 in Q3 2025.

Analysis

BullFrog AI Holdings (BFRG) Cash from Financing Activities (2022 - 2025) Analysis & Trends

BullFrog AI Holdings (BFRG) has reported Cash from Financing Activities for 4 consecutive years, with $1.4 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities fell 44.19% year-over-year to $1.4 million; the trailing twelve-month figure through Dec 2025 stood at $2.4 million (down 71.8% YoY), and the FY2025 full-year result was $2.4 million, down 71.8% from the prior year.
  • Cash from Financing Activities rose to $1.4 million in Q4 2025 per BFRG's latest filing, from $624249.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $7.7 million in Q1 2023 and bottomed at -$213290.0 in Q4 2023.
  • Historically, Cash from Financing Activities has averaged $1.3 million across 4 years, with a median of $186375.0 in 2025.
  • The widest YoY moves for Cash from Financing Activities: up 32418.68% in 2023, down 487.1% in 2023.
  • Over 4 years, Cash from Financing Activities stood at $55100.0 in 2022, then slumped by 487.1% to -$213290.0 in 2023, then soared by 1257.59% to $2.5 million in 2024, then slumped by 44.19% to $1.4 million in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered $1.4 million, $624249.0, and $208680.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -1.48 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 2.34 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn -426.70 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn -1.22 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 14.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 36.24 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 1.30 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 27.18 Mn
10 BullFrog AI Holdings 9.27 Mn 2.35 Mn 106,899.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.38 Mn
Sep 30, 2025 624,249.00
Jun 30, 2025 208,680.00
Mar 31, 2025 164,070.00
Dec 31, 2024 2.47 Mn
Sep 30, 2024 -169,035.00
Jun 30, 2024 -166,114.00
Mar 31, 2024 6.29 Mn
Dec 31, 2023 -213,290.00
Sep 30, 2023 -209,761.00
Jun 30, 2023 1.27 Mn
Mar 31, 2023 7.72 Mn
Dec 31, 2022 55,100.00
Sep 30, 2022 63,000.00
Jun 30, 2022 825,440.00
Mar 31, 2022 23,750.00